4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Novolog (Pharm-Up 1966) Ltd (NVLG) operates in the Medical Distribution industry and is headquartered in Modi'in-Maccabim-Re'ut, Israel with about 916 employees. Its market capitalization is roughly ₪378 million. In the fiscal year ended 2025-12-31, NVLG reported ₪1.8B in revenue and ₪4M in net income.
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | ₪1.8B | ₪2.0B | ₪1.6B | ₪1.5B | — |
| Gross Profit | ₪138M | ₪181M | ₪169M | ₪176M | — |
| Operating Income (EBIT) | ₪26M | ₪70M | ₪50M | ₪78M | — |
| Net Income | ₪4M | ₪40M | (₪42M) | ₪48M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₪506M | ₪373M | ₪484M | ₪442M | ₪507M | — |
| Gross Profit | ₪31M | ₪33M | ₪37M | ₪36M | ₪32M | — |
| Operating Income (EBIT) | ₪5M | ₪6M | ₪11M | ₪7M | ₪3M | — |
| Net Income | ₪0M | (₪6M) | ₪4M | ₪5M | ₪1M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₪20M) | (₪40M) | (₪17M) | (₪32M) | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | (₪10M) | (₪10M) | — | — | (₪10M) |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | ₪2.1B | ₪3.0B | ₪2.8B | ₪2.4B | — |
| Total Liabilities | ₪1.8B | ₪2.7B | ₪2.4B | ₪2.0B | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NVLG viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms